This month’s (March) patient meeting included a presentation by Endocrinology Specialist Nurses from Manchester Royal Infirmary. This was a talk we requested as we know secondary adrenal insufficiency is a concern for many patients.
Allergic bronchopulmonary aspergillosis (ABPA) is a complex respiratory condition that occurs when the immune system overreacts to the Aspergillus fungus, leading to inflammation and potential lung damage. To manage the symptoms of ABPA, patients are often prescribed corticosteroid medications. However, long-term use of these medications can lead to a condition called secondary adrenal insufficiency. Watch the talk below to learn more about the condition, it’s diagnosis, management and treatment.
Share this post
Latest News posts
Sex and breathlessness
November 18, 2022
Managing Chronic Pain
November 18, 2022
Recognising and avoiding depression
November 18, 2022
Plugs and Slugs
November 10, 2022
Living with CPA and ABPA
October 31, 2022
Rare disease patient journey to diagnosis
October 24, 2022
Talking to Friends and Family about Aspergillosis
October 24, 2022
Ear, Eye and Nail Aspergillus infections
October 10, 2022
ISHAM Award for Prof Malcolm Richardson
September 28, 2022
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video